FDA — authorised 23 May 1980
- Application: NDA018300
- Marketing authorisation holder: MOLNLYCKE HLTH
- Local brand name: HIBISTAT
- Indication: SOLUTION — TOPICAL
- Status: approved
FDA authorised 70% alcohol - 0.5% clorhexidine on 23 May 1980
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 23 May 1980; FDA authorised it on 24 December 1984; FDA authorised it on 17 December 1985.
MOLNLYCKE HLTH holds the US marketing authorisation.